These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30307785)

  • 21. Cardiovascular response to prescribed detraining among recreational athletes.
    Pedlar CR; Brown MG; Shave RE; Otto JM; Drane A; Michaud-Finch J; Contursi M; Wasfy MM; Hutter A; Picard MH; Lewis GD; Baggish AL
    J Appl Physiol (1985); 2018 Apr; 124(4):813-820. PubMed ID: 29212672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of family hypertension history on exercise-induced cardiac remodeling.
    Baggish AL; Weiner RB; Yared K; Wang F; Kupperman E; Hutter AM; Picard MH; Wood MJ
    Am J Cardiol; 2009 Jul; 104(1):101-6. PubMed ID: 19576328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of an endurance training program on exercise-induced cardiac biomarker release.
    Legaz-Arrese A; López-Laval I; George K; Puente-Lanzarote JJ; Mayolas-Pi C; Serrano-Ostáriz E; Revilla-Martí P; Moliner-Urdiales D; Reverter-Masià J
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H913-20. PubMed ID: 25681432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
    Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
    Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure.
    Pastormerlo LE; Agazio A; Benelli E; Gabutti A; Poletti R; Prontera C; Clerico A; Emdin M; Passino C
    Am J Cardiol; 2015 Aug; 116(4):567-72. PubMed ID: 26089013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of endurance exercise training on left ventricular torsion.
    Weiner RB; Hutter AM; Wang F; Kim J; Weyman AE; Wood MJ; Picard MH; Baggish AL
    JACC Cardiovasc Imaging; 2010 Oct; 3(10):1001-9. PubMed ID: 20947045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
    Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
    Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced left ventricular performance in endurance trained older men.
    Seals DR; Hagberg JM; Spina RJ; Rogers MA; Schechtman KB; Ehsani AA
    Circulation; 1994 Jan; 89(1):198-205. PubMed ID: 8281647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy.
    Dunn ME; Manfredi TG; Agostinucci K; Engle SK; Powe J; King NM; Rodriguez LA; Gropp KE; Gallacher M; Vetter FJ; More V; Shimpi P; Serra D; Colton HM;
    Toxicol Pathol; 2017 Feb; 45(2):344-352. PubMed ID: 27102652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Speckle tracking evaluation in endurance athletes: the "optimal" myocardial work.
    D'Andrea A; Radmilovic J; Carbone A; Mandoli GE; Santoro C; Evola V; Bandera F; D'Ascenzi F; Bossone E; Galderisi M; Cameli M;
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1679-1688. PubMed ID: 32367187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between biomarkers and left ventricular filling pressures at rest and during exercise in patients after myocardial infarction.
    Andersen MJ; Ersbøll M; Bro-Jeppesen J; Møller JE; Hassager C; Køber L; Borlaug BA; Goetze JP; Gustafsson F
    J Card Fail; 2014 Dec; 20(12):959-67. PubMed ID: 25285749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
    Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt PR
    J Hypertens; 2005 May; 23(5):1083-90. PubMed ID: 15834296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological changes and myocardial function assessed by traditional and novel echocardiographic methods in preadolescent athlete's heart.
    Bjerring AW; Landgraff HE; Leirstein S; Aaeng A; Ansari HZ; Saberniak J; Murbræch K; Bruun H; Stokke TM; Haugaa KH; Hallén J; Edvardsen T; Sarvari SI
    Eur J Prev Cardiol; 2018 Jun; 25(9):1000-1007. PubMed ID: 29785884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
    Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
    Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.